During the 45-day comment period the DME MACs received a total of 2 comments.
Introduction to Responses
The DME MACs appreciate the comments received from stakeholders during the open comment period on the proposed Nebulizers Local Coverage Determination (LCD).
Pursuant to the CMS Program Integrity Manual (CMS Pub. 100-08) Chapter 13:
In conducting a review, MACs shall use the available evidence of general acceptance by the medical community, such as published original research in peer-reviewed medical journals, systematic reviews and meta-analyses, evidence-based consensus statements and clinical guidelines.
Accordingly, the final policy and our response to comments are based on the best currently available published clinical evidence, to support optimal health outcomes in Medicare beneficiaries with a diagnosis of chronic obstructive pulmonary disease (COPD).